CEACAM5 and colorectal carcinoma: In the realm of colorectal cancer (CRC), where CEA and CA199 traditionally serve as primary tumor biomarkers, the emergence of 5′-tRF-GlyGCC as a markedly elevated entity in CRC patient plasma warrants attention.